Načítá se...
Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
The proteasome plays a vital role in the degradation of proteins involved in several pathways including the cell cycle, cellular proliferation and apoptosis and is a validated target in cancer treatment. Bortezomib (Velcade(®), PS-341) is the first US FDA approved proteasome inhibitor anticancer dru...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3307794/ https://ncbi.nlm.nih.gov/pubmed/22012631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2011.814 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|